Home > News > Tapping into a tiny niche with grand applications
November 12th, 2007
Tapping into a tiny niche with grand applications
Abstract:
Sometimes the key to success is finding a niche and exploiting your specialist knowledge of it. For New York-based venture capital fund Harris & Harris, the niche could not be smaller - it invests in companies involved in nanotechnology (its ticker on Nasdaq is TINY).
Harris & Harris is a classic early stage VC firm, says Mr Harris, except for two facts - first, it only invests in "tiny technology" and second, "we only invest our own capital". Because it is a publicly held company that invests only its own, permanent capital, it can be an unusually patient investor, he says. This is useful in a sector that has seen $8bn (£3.8bn, €5.4bn) poured into it by VC firms over the last 10 years but has seen little in the way of exit opportunities.
Source:
ft.com
Bookmark:
| Related News Press |
VC/Funding/Angel financing/Loans/Leases/Crowdfunding
Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||